GaN

Search documents
8英寸量产!2个GaN项目披露新进展
行家说三代半· 2025-05-08 10:20
插播: 倒计时7天! 三 菱 电 机 、 意 法 半 导 体 、 Wolfspeed、三安半导体、天科合达、元山电子、大族半导体、香港大学、长飞先进、宏微科技、 利普思、昕感科技、国扬电子、国基南方、芯长征、合盛新材料、瀚天天成、芯研科、国瓷功能材 料等邀您参加上海"电动交通&数字能源SiC技术应用及供应链升级大会",点击文章底部 "阅读原 文" 即可报名参会。 韩国 APRO Semicon : 龟尾工厂 开始量产 8 英寸氮化镓外延片; 印度 Polymatech:投资9.3亿 建设 GaN 芯片工厂。 APRO Semicon 表示,他 们将通过大规模设施投资和技术研发,以提高工艺设计及制造等各个方面的实 力,并 跃升为全球GaN功率半导体市场的关键公司。 近期,"行家说三代半"发现,业界有2个氮化镓项目正在加速推进: APRO Semicon: 8英寸GaN工厂开始量产 近日,据韩 国电子时报等媒体报道, APRO Semicon的 龟 尾新工厂 已开始 量产 8 英寸氮化镓外延片。 图:APRO 报道进一步透露,该工厂已于 去年 12 月竣工,开始生产 用于 650V 功率半导体的"硅基氮化镓"外延 ...
Guild pany(GHLD) - 2025 Q1 - Earnings Call Transcript
2025-05-07 22:02
Guild Company (GHLD) Q1 2025 Earnings Call May 07, 2025 05:00 PM ET Company Participants None - ExecutiveTerry Schmidt - CEO & DirectorDavid Neylan - President & COOAmber Kramer - SVP & CFODonald Fandetti - Managing DirectorMikhail Goberman - VP - Equity Research Conference Call Participants Richard Shane - AnalystJake Katsikas - Equity Research Analyst Operator Good afternoon, ladies and gentlemen, and welcome to the Guild Holdings Company First Quarter twenty twenty five Earnings Conference Call. At this ...
biote (BTMD) - 2025 Q1 - Earnings Call Transcript
2025-05-07 22:00
biote Corp (BTMD) Q1 2025 Earnings Call May 07, 2025 05:00 PM ET Speaker0 Hello, and welcome to the Biodi First Quarter twenty twenty five Earnings Conference Call. All participants will be in listen only mode. After today's presentation, there will be an opportunity to ask questions. Please note this event is being recorded. I would now like to turn the conference over to Simon Sarovietki. Please go ahead. Speaker1 Thank you for joining us today. This afternoon, Bati published financial results for the fir ...
Should You Buy or Hold Sprouts Farmers Market Stock Post Q1 Earnings?
ZACKS· 2025-05-07 17:15
Core Viewpoint - Sprouts Farmers Market reported strong first-quarter 2025 results, leading to discussions among investors regarding the stock's future direction and potential investment strategies [1][2]. Financial Performance - The company reported better-than-expected results with year-over-year increases in both top and bottom lines, driven by comparable sales growth of 11.7%, e-commerce sales growth of 28%, and robust traffic trends [2][3]. - For the full year 2025, Sprouts Farmers anticipates net sales growth of 12% to 14% and comparable store sales growth of 5.5% to 7.5%, with adjusted earnings per share projected between $4.94 and $5.10, up from $3.75 in 2024 [3][4]. Analyst Sentiment - Wall Street analysts have raised their earnings estimates for Sprouts Farmers, with the Zacks Consensus Estimate increasing by 5.8% to $4.95 for the current fiscal year and 4.7% to $5.56 for the next fiscal year, indicating year-over-year increases of 32% and 12.2% respectively [4]. Growth Strategy - The company is focusing on product innovation, technology, and competitive pricing, which is expected to drive sales growth in the natural and organic market [5][6]. - Sprouts Farmers has expanded its store count to 443 across 24 states and plans to open at least 35 new stores in 2025, with 120 approved stores in the pipeline [8]. Financial Discipline - The company generated $299.1 million in operating cash flow in the first quarter, allowing for $49 million in capital expenditures and $219 million in share repurchases [9]. Market Positioning - Sprouts Farmers' stock has outperformed its peers, with a 17.2% increase over the past month compared to the industry's 16.9% growth [10][11]. - The stock is trading at a premium, with a forward 12-month price-to-sales ratio of 1.84, significantly higher than the industry average of 0.26 and its peers [12][14]. Investment Outlook - The company's strong sales performance, expansion plans, and differentiated product offerings position it well for sustained growth, making it a compelling investment opportunity [15].
ParkOhio(PKOH) - 2025 Q1 - Earnings Call Transcript
2025-05-07 15:02
Park-Ohio (PKOH) Q1 2025 Earnings Call May 07, 2025 10:00 AM ET Company Participants Matthew V. Crawford - Chairman, CEO & DirectorPatrick Fogarty - VP & CFOJacob Moore - Equity Research AssociateDave Storms - Director of Equity Research Operator Good morning, and welcome to Park Ohio First Quarter twenty twenty five Results Conference Call. At this time, all participants are in a listen only mode. After the presentation, the company will conduct a question and answer session. Today's conference is also bei ...
Voya Financial(VOYA) - 2025 Q1 - Earnings Call Transcript
2025-05-07 15:00
Voya Financial (VOYA) Q1 2025 Earnings Call May 07, 2025 10:00 AM ET Speaker0 Good morning. Welcome to Voya Financial's First Quarter twenty twenty five Earnings Conference Call. All participants will be in a listen only mode. Please note this event is being recorded. I would now like to turn the call over to May Nie Chew, Head of Investor Relations. Please go ahead. Speaker1 Good morning and thank you for joining us for Voya Financial's first quarter twenty twenty five earnings conference call. As a remind ...
Techne (TECH) Reports Q3 Earnings: What Key Metrics Have to Say
ZACKS· 2025-05-07 14:36
Core Insights - Techne (TECH) reported revenue of $316.18 million for the quarter ended March 2025, reflecting a year-over-year increase of 4.2% and surpassing the Zacks Consensus Estimate by 0.30% [1] - The company's EPS was $0.56, up from $0.48 in the same quarter last year, resulting in an EPS surprise of 9.80% compared to the consensus estimate of $0.51 [1] Financial Performance - Organic Growth was reported at 6%, exceeding the average estimate of 5.2% from three analysts [4] - Organic Growth in Diagnostics and Genomics was 2%, below the two-analyst average estimate of 6.2% [4] - Organic Growth in Protein Sciences was 7%, significantly higher than the average estimate of 2.8% from two analysts [4] - Net Sales from intersegment revenue was -$0.74 million, worse than the average estimate of -$0.55 million, representing a year-over-year decline of 3.7% [4] - Net Sales in Protein Sciences reached $227.69 million, surpassing the average estimate of $224.75 million, with a year-over-year increase of 6.1% [4] - Net Sales in Diagnostics and Genomics were $89.23 million, slightly below the average estimate of $92.50 million, showing a year-over-year growth of 2% [4] Market Performance - Techne's shares have returned -2.2% over the past month, contrasting with the Zacks S&P 500 composite's increase of 10.6% [3] - The stock currently holds a Zacks Rank 4 (Sell), indicating potential underperformance relative to the broader market in the near term [3]
SeaStar Medical to Report First Quarter Financial Results on May 14, 2025
Globenewswire· 2025-05-07 14:00
DENVER, May 07, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing organ failure and potential loss of life, announced today that it will report its first quarter financial results after market close on Wednesday, May 14, 2025, and host a webcast and conference call to discuss its financial results and business progress. A replay of the call will be available after 7:30 pm ET ...
IAMGOLD(IAG) - 2025 Q1 - Earnings Call Transcript
2025-05-07 13:30
IAMGOLD (IAG) Q1 2025 Earnings Call May 07, 2025 08:30 AM ET Speaker0 Thank you for standing by. This is the conference operator. Welcome to the IAMGOLD First Quarter twenty twenty five Operating and Financial Results Conference Call and Webcast. As a reminder today, all participants are in listen only mode and the conference is being recorded. After the presentation, there will be an opportunity to ask questions. At this time, I would like to turn the conference over to Graham Jennings, VP, Investor Relati ...
Lantheus Holdings(LNTH) - 2025 Q1 - Earnings Call Transcript
2025-05-07 13:02
Lantheus (LNTH) Q1 2025 Earnings Call May 07, 2025 08:00 AM ET Company Participants Mark Kinarney - VP - Investor RelationsBrian Markison - CEO & DirectorPaul Blanchfield - PresidentAmanda Morgan - Chief Commercial OfficerRobert Marshall - CFO & TreasurerAnthony Petrone - Managing DirectorRichard Newitter - Managing DirectorMatthew Taylor - Managing DirectorYuan Zhi - Managing Director Conference Call Participants Roanna Ruiz - Senior Managing Director, Biotechnology AnalystNone - AnalystLarry Solow - Partn ...